PKM and non-small cell lung carcinoma: PKM2 expression has been associated with esophageal squamous cell carcinoma (ESCC) chemoresistance [11], while its knockdown in non-small cell lung cancer (NSCLC) increased the radiosensitivity of resistant cell lines [12].